Your browser doesn't support javascript.
loading
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance.
Martin, Claire A; Cullinane, Carleen; Kirby, Laura; Abuhammad, Shatha; Lelliott, Emily J; Waldeck, Kelly; Young, Richard J; Brajanovski, Natalie; Cameron, Donald P; Walker, Rachael; Sanij, Elaine; Poortinga, Gretchen; Hannan, Ross D; Pearson, Richard B; Hicks, Rodney J; McArthur, Grant A; Sheppard, Karen E.
Afiliación
  • Martin CA; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Cullinane C; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Kirby L; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic, Australia.
  • Abuhammad S; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Waldeck K; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic, Australia.
  • Young RJ; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Brajanovski N; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic, Australia.
  • Cameron DP; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Walker R; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Sanij E; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Poortinga G; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Hannan RD; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Pearson RB; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Hicks RJ; Department of Pathology, University of Melbourne, Parkville, Vic, Australia.
  • McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia.
  • Sheppard KE; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic, Australia.
Int J Cancer ; 142(10): 2139-2152, 2018 05 15.
Article en En | MEDLINE | ID: mdl-29243224
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Quinasas Quinasa Quinasa PAM / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Melanoma Límite: Animals / Female / Humans Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Quinasas Quinasa Quinasa PAM / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Melanoma Límite: Animals / Female / Humans Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Australia